# ZD6474 to Treat Advanced Brain Cancer in Patients

> **NCT00272350** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 83 (actual)

## Conditions studied

- Recurrent High-Grade Gliomas
- Progressive Low-Grade Gliomas
- Malignant Gliomas

## Interventions

- **DRUG:** Steroids
- **DRUG:** ZD6474

## Key facts

- **NCT ID:** NCT00272350
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12-29
- **Primary completion:** 2014-02-27
- **Final completion:** 2014-02-27
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2019-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00272350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00272350, "ZD6474 to Treat Advanced Brain Cancer in Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00272350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*